Fundz

T2 Biosystems to sell $8M in private placement for working capital and general corporate purposes

PRIVATEMay 16, 2024

Amount Raised

$8 Million

Round Type

Post-IPO Equity

LexingtonManufacturingBiotechnologyHealthcareHealth Care

Investors

H.C. Wainwright & Co.

Description

T2 Biosystems has signed an agreement to sell approximately $8 million in shares and warrants to a group of investors for working capital and general corporate purposes. The private placement is expected to close on or about May 17.

Quick answer

T2 Biosystems raised $8 Million in a Post-IPO Equity round, dated May 16, 2024. Investors: H.C. Wainwright & Co. T2 Biosystems is based in Lexington, Massachusetts, United States.

How much did T2 Biosystems raise?
T2 Biosystems raised $8 Million in a Post-IPO Equity round on May 16, 2024.
Who invested in T2 Biosystems?
H.C. Wainwright & Co. is named as investors in this round.
What does T2 Biosystems do?
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat..
Where is T2 Biosystems based and how big is it?
T2 Biosystems is based in Lexington, Massachusetts, United States.
Who are the decision-makers at T2 Biosystems?
Fundz holds 1 contact at T2 Biosystems. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Manufacturing around the same time

Companies in the same sectors as T2 Biosystems that raised within 45 days of this round, from Fundz verified event records.

  • Route 92 Medical raised $50M on June 28, 2024.
  • NewcelX raised $787K on June 28, 2024.
  • Novabay raised $226K on June 14, 2024.
  • Omniscient Neurotechnology raised $60M (Series C) on June 11, 2024.
  • Endovia Health Sciences, Inc. raised $1.9M (Seed) on May 1, 2024.
  • Aspira Women’s Health raised $1.9M on June 30, 2024.

Who to call at T2 Biosystems, and when

A new round usually means T2 Biosystems is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day T2 Biosystems raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at T2 Biosystems, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at T2 Biosystems. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

T2 Biosystems

Location

Lexington, Massachusetts, United States

About

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, the T2BiothreatTM Panel, and the T2SARS-CoV-2TM Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the expanded T2Bacteria Panel to add Acinetobacter baumannii, the Candida auris test, and the T2LymeTM Panel, as well as next-generation products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment T2 Biosystems raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts16 people are listed at T2 Biosystems. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for T2 Biosystems's next move

See what Strategic adds

T2 Biosystems raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.